NEW YORK ( TheStreet) -- Jazz Pharmaceuticals (Nasdaq: JAZZ) hit a new 52-week high Tuesday as it is currently trading at $35.18, above its previous 52-week high of $34.97 with 238,297 shares traded as of 10:16 a.m. ET. Average volume has been 778,200 shares over the past 30 days. Jazz has a market cap of $1.4 billion and is part of the health care sector and drugs industry. Shares are up 76.8% year to date as of the close of trading on Friday. Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States. The company has a P/E ratio of 27.4, below the average drugs industry P/E ratio of 28.3 and above the S&P 500 P/E ratio of 17.7.
- Practice your JAZZ trading strategies and win cash in our stock game.